Skip to main content
THURSDAY,
MAY 26, 2022
THURSDAY,
MAY 26, 2022
Home
Economy
Stocks
Analysis
World+Biz
Sports
Splash
Features
Videos
Long Read
Games
Epaper
More
COVID-19
Bangladesh
Infograph
Interviews
Offbeat
Thoughts
Podcast
Quiz
Tech
Subscribe
Archive
Trial By Trivia
Magazine
Supplement
বাংলা
Pfizer Covid-19 Vaccine
Coronavirus chronicle
Pfizer says 3 Covid shots protect children under 5
Coronavirus chronicle
Pfizer eyes Covid vaccine for all variants before 2023
Coronavirus chronicle
Pfizer-BioNTech seek US approval of second Covid booster for 65+
Covid-19 in Bangladesh
Bangladesh receives 10m more Pfizer doses from US
Coronavirus chronicle
Pfizer forecasts $54 bln in 2022 sales of Covid vaccine, pill
Coronavirus chronicle
China's Sinovac Covid-19 booster weaker against Omicron - Hong Kong study
Coronavirus chronicle
Pfizer says Covid-19 pill near 90% effective in final analysis
Coronavirus chronicle
Pfizer booster study lifts mood over Omicron variant
Coronavirus chronicle
Study suggests Pfizer Covid-19 vaccine may only partially protect against Omicron
Coronavirus chronicle
Mixing Pfizer, AstraZ Covid-19 shots with Moderna gives better immune response: Study
Coronavirus chronicle
Pfizer's Covid-19 vaccine trial data shows long-term efficacy in adolescents
Coronavirus chronicle
Pfizer to conduct trials of antiviral Covid-19 pill in Russia
Coronavirus chronicle
Canada authorises Pfizer Covid vaccine booster for adults
Show More